CausalSentinel

Protein Dossier — B4GAT1 (Beta-1,4-glucuronyltransferase 1)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Amyotrophic lateral sclerosis 0.196 0.0667 0.00332 Wald ratio 1 trans NA
Depressive symptoms -0.0211 0.0121 0.0801 Wald ratio 1 trans NA
Rheumatoid arthritis -0.0892 0.0526 0.0899 Wald ratio 1 trans NA
High grade serous ovarian cancer -0.0897 0.059 0.129 Wald ratio 1 trans NA
Hippocampus volume 26.5 17.5 0.13 Wald ratio 1 trans NA
Neuroticism 0.0181 0.0121 0.134 Wald ratio 1 trans NA
Eczema 0.0771 0.0652 0.238 Wald ratio 1 trans NA
Alzheimer’s disease -0.0643 0.0601 0.284 Wald ratio 1 trans NA
ER-negative Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.0414 0.0426 0.331 Wald ratio 1 trans NA
Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.0199 0.0235 0.397 Wald ratio 1 trans NA
ER-positive Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.0235 0.0281 0.402 Wald ratio 1 trans NA
Intracranial volume -5.8e+03 7.19e+03 0.42 Wald ratio 1 trans NA
…and 3 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

28 association rows across 26 traits (11 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating B4GAT1 levels 1e-394 rs10896113 1 GCST90860648 no MR -> candidate analysis
Bone mineral density mean 2e-48 rs116864252 1 GCST90321120 no MR -> candidate analysis
Diverticulosis and diverticulitis (PheCode 562) 1e-13 rs35166611 2 GCST90476073 no MR -> candidate analysis
Diverticulosis (PheCode 562.1) 3e-11 rs35166611 1 GCST90480328 no MR -> candidate analysis
Waist-hip ratio 4e-11 rs68162171 1 GCST007067 no MR -> candidate analysis
Serum metabolite levels 6e-11 rs4930176 2 GCST012021 no MR -> candidate analysis
Bioavailable testosterone levels 3e-9 rs7395670 1 GCST90012104 no MR -> candidate analysis
Arachidonic acid levels 2e-8 rs3177514 1 GCST90383909 no MR -> candidate analysis
Body shape phenotype PC3 3e-8 rs68162171 1 GCST90832991 no MR -> candidate analysis
Hyperuricemia in low fat intake 5e-8 rs570853927 1 GCST90693156 no MR -> candidate analysis
Hyperuricemia in low folate intake 5e-8 rs570853927 1 GCST90693181 no MR -> candidate analysis
Hyperuricemia 6e-8 rs570853927 1 GCST90693152 no MR -> candidate analysis
…and 14 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 320 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13 0.801 established (curated) no MR -> candidate analysis
muscular dystrophy-dystroglycanopathy, type A 0.608 established (curated) no MR -> candidate analysis
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 0.426 established (curated) no MR -> candidate analysis
hereditary disease 0.315 established (curated) no MR -> candidate analysis
gout 0.264 common-variant locus no MR -> candidate analysis
46,XX gonadal dysgenesis 0.195 established (curated) no MR -> candidate analysis
genetic non-acquired premature ovarian failure 0.195 established (curated) no MR -> candidate analysis
handedness 0.18 common-variant locus no MR -> candidate analysis
diverticular disease 0.138 common-variant locus no MR -> candidate analysis

Of the 9 rows above, 9 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=0.0051, LOEUF=0.762 — LoF-tolerant
GWAS Catalog 70 unique SNPs / 140 rows
ClinVar 267 records; 3 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance